HF
ACHV icon

HRT Financial’s Achieve Life Sciences ACHV Stock Holding History

HRT Financial’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,579
Closed -$92K – 4069
2026
Q1 		$92K Buy
31,579
+12,721
+67% +$56.5K ﹤0.01% 3365
2025
Q4 		$93K Buy
+18,858
New +$82.2K ﹤0.01% 2797
2023
Q1 		– Sell
-13,031
Closed -$32K – 2412
2022
Q4 		$32K Buy
+13,031
New +$33.4K ﹤0.01% 2138
2020
Q1 		– Sell
-539
Closed -$5K – 718
2019
Q4 		$5K Buy
+539
New +$11.6K ﹤0.01% 1098

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HRT Financial's ACHV Position: Q2 2026 in Review

HRT Financial sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 31,579 shares — an estimated $92K sold.

HRT Financial first reported a position in ACHV in Q4 2019 and held it in 4 quarters. The position peaked at $93K in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • HRT Financial reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 31,579 Achieve Life Sciences shares in Q2 2026, an estimated $92K.
  • HRT Financial first reported a position in Achieve Life Sciences in Q4 2019 and held it in 4 quarters.
  • HRT Financial's Achieve Life Sciences position peaked at $93K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.